Cancer Information Highlights, June 20, 2018

Cancer Information Highlights, June 20, 2018

Cancer Information Highlights From the National Cancer Institute Updating you about cancer causes, prevention, screening, treatment, coping, and more   New from NCI Trial Results May Change Standard Treatment for T-Cell Acute Lymphoblastic Leukemia   An NCI-funded trial tested the addition of nelarabine (Arranon) to standard treatment for children and young adults with T-cell acute lymphoblastic leukemia (T-ALL). Progress Made Treating Children with Neurofibromatosis   Early clinical trial results show that an experimental drug can shrink tumors in children and young adults who have a genetic syndrome called neurofibromatosis type 1 (NF1) and may improve symptoms such as pain and problems with movement. Potential New Treatment Option for Rare Leukemia People diagnosed with hairy cell leukemia (HCL) may have an effective new treatment option: moxetumomab pasudotox, a type of drug called an immunotoxin. Read more about how well this treatment worked in a phase 3 clinical trial in patients with advanced HCL. Immunotherapy Targets Breast Cancer Mutations Learn about an experimental approach to immunotherapy that caused all signs of cancer to disappear in a patient whose breast cancer did not respond to any other treatments. Human Papillomavirus (HPV) Vaccines HPV vaccines protect against HPV infection. Learn about the different types of HPV and the conditions they can cause, who should get the vaccine, how effective the vaccines are, and why vaccination is important. Video—The Cancer Genome Atlas Legacy   Watch this video celebrating the The Cancer Genome Atlas program's accomplishments and contributions to learn how the program has revolutionized cancer research and ushered in the era of precision medicine. Video—Adult Brain and Spinal Tumor Research and Development  If you missed the live broadcast, you can now watch the recording of our Facebook Live event. Listen to our panel of experts discuss adult brain and spine tumor research and treatment. Learn how these tumors are diagnosed and treated and how they affect patients’ quality of life.

Also of Interest Survivorship Many cancer survivors say that they felt they had a lot of support during their treatment, but once it ended it was hard to make a transition to a new way of life. Visit this page to find information about what to expect once treatment is over, medical care for patients who have finished treatment, and side effects that may still occur. Leukemia Leukemia is cancer of the blood cells. Visit this page to learn about the types of leukemia and their treatment, who is at risk, and basic statistics. Improving Outcomes for Patients with NF1 This story from the NCI Annual Plan and Budget Proposal FY 2019 explains how a child with NF1 has benefited from an NCI clinical trial led by Brigitte Widemann, M.D. Learn what causes NF1 and about previous research that led to this trial.